Publication — IRIC MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. Publication date April 1, 2018 Principal Investigators Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, Bhola P, O'Donnell C, Spitzer B, Stutzke C, Lavallée VP, Hébert J, Krivtsov AV, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G, Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A PubMed reference Cancer Discov 2018;8(4):478-497 PubMed ID 29431698 Affiliation Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.